Principles for Pooled Procurement
The AMR Industry Alliance’s pooled procurement principles help purchasers in low- and lower-middle-income countries engage the private sector to source antibiotics and diagnostics.
SECURE Coordinated Procurement 2026 Report
A March 2026 report on coordinated procurement, linked to the SECURE initiative.
GARDP-SECURE Update, April 14, 2026
A presentation updating partners on work with GARDP and the SECURE initiative, April 2026.
AMR Industry Alliance Releases “Principles for Pooled Procurement of AMR Products”
The AMR Industry Alliance is proud to announce the publication of its new guidance document: “Principles for Pooled Procurement of AMR Products.” This document is intended to support purchasers in low- and lower-middle-income countries (LMICs) in establishing pooled procurement mechanisms (PPMs) for antimicrobial-resistance (AMR) products—including antibiotics and diagnostics. The guidance highlights the role that private-sector […]
NHS launches ‘subscription’ scheme for antibiotics with pharma sector
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse The NHS will agree subscription-style deals with drugmakers for antibiotics, as the UK seeks to encourage the development of new medicines and curb antimicrobial resistance caused by their overuse. The NHS on Monday said it would negotiate fixed fees to […]
Improved Utilization of Diagnostics will Better Inform Stewardship Practice
AMR Industry Alliance Launches 2024 Equitable and Responsible Access Roadmap
The AMR Industry Alliance released its Equitable & Responsible Access Roadmap highlighting key barriers to diagnostics and antimicrobial access — and outlining solutions to tackle the barriers of regulatory issues, demand forecasting, and procurement challenges. The Equitable & Responsible Access Roadmap identifies the following key barriers to diagnostic access Diagnostics Infrastructure: Inadequate health system infrastructure hinders […]
AMR Industry Alliance Launches New Report on Role of Diagnostics in National Action Plans
Geneva – April 30, 2024 – A new report from the AMR Industry Alliance examines the role of diagnostics in national action plans (NAPs) and highlights successful examples integrating and implementing diagnostics into NAPs in LMICs to combat AMR. Based on a review of the Global Database for Tracking Antimicrobial resistance (AMR) Country Self-Assessment Survey […]
Equitable & Responsible Access Roadmap
The AMR Industry Alliance advances equitable access to antimicrobials and diagnostics through collaborative, patient-focused solutions.
AMR Industry Alliance Awards South Africa’s NeoAMS Program the 2023 AMR Stewardship Prize
NeoAMS program targets inappropriate antibiotic use among hospitalized newborns. Geneva – 7 December 2023 – The AMR Industry Alliance, the largest coalition of life sciences companies dedicated to combatting antimicrobial resistance (AMR), today announced that South Africa’s NeoAMS Program won its 2023 Stewardship Prize. The Stewardship Prize acknowledges local programs’ innovative approaches to AMR stewardship […]